Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors

NCT07691619 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
49
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tianjin Medical University Cancer Institute and Hospital